Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center-Reference-Cited by-同舟云学术

Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center

Published:2019-05 Issue: Volume:112 Page:83-93
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Harrison Rebecca A.^ORCID,Anderson Mark D.,Cachia David,Kamiya-Matsuoka Carlos,Weathers Shiao-Pei S.,O'Brien Barbara J.,Penas-Prado Marta,Yung W.K. Alfred,Wu Jimin,Yuan Ying,de Groot John F.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma;Chinot;N Engl J Med,2014

2. A randomized trial of bevacizumab for newly diagnosed glioblastoma;Gilbert;N Engl J Med,2014

3. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial;Stupp;Jama,2017

4. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011;Ostrom;Neuro Oncol,2014

5. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010;Ostrom;Neuro Oncol,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme;Translational Oncology;2023-10

2. Machine learning based survival prediction in Glioma using large-scale registry data;Health Informatics Journal;2022-10

3. Extending Our Reach: Expanding Enrollment in Brain Metastases and Primary Brain Tumor Clinical Trials;American Society of Clinical Oncology Educational Book;2022-07

4. Analysis of factors leading to early termination in glioblastoma-related clinical trials;Journal of Neuro-Oncology;2022-06-01

5. Clinical and survival characteristics of primary and secondary gliosarcoma patients;Clinical Neurology and Neurosurgery;2022-03